Characterization of blaOXA-143 Variants in Acinetobacter baumannii and Acinetobacter pittii

OXA-235, a Novel Class D β-Lactamase Involved in Resistance to Carbapenems in Acinetobacter baumannii

(2013) Paul G. Higgins et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Emergence of OXA-72-producing Acinetobacter pittii clinical isolates

(2013) Rémy A. Bonnin et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Dissemination and characterization of NDM-1-producing Acinetobacter pittii in an intensive care unit in China

(2012) J. Yang et al.   CLINICAL MICROBIOLOGY AND INFECTION

Molecular epidemiology of Acinetobacter baumannii and Acinetobacter nosocomialis in Germany over a 5-year period (2005–2009)

(2012) X. Schleicher et al.   CLINICAL MICROBIOLOGY AND INFECTION

The Rise of Carbapenem-Resistant Acinetobacter baumannii

(2012) Benjamin A. Evans et al.   CURRENT PHARMACEUTICAL DESIGN

High prevalence of OXA-143 and alteration of outer membrane proteins in carbapenem-resistant Acinetobacter spp. isolates in Brazil

(2012) Anna Karina Mostachio et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Detection of OXA-231, a new variant of blaOXA-143, in Acinetobacter baumannii from Brazil: a case report

(2012) B. Gionco et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Association between β-Lactamase-EncodingblaOXA-51Variants and DiversiLab Rep-PCR-Based Typing of Acinetobacter baumannii Isolates

(2012) Esther Zander et al.   JOURNAL OF CLINICAL MICROBIOLOGY

The Success of Acinetobacter Species; Genetic, Metabolic and Virulence Attributes

(2012) Anton Y. Peleg et al.   PLoS One

Low Prevalence ofblaOXA-143in Private Hospitals in BrazilAuthors' Reply

(2011) Jéssica S. Werneck et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Acinetobacter infection - an emerging threat to human health

(2011) Paolo Visca et al.   IUBMB LIFE

Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007

(2011) Yvonne Pfeifer et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus–Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU)

(2011) Alexandr Nemec et al.   RESEARCH IN MICROBIOLOGY

High Prevalence of Carbapenem-ResistantAcinetobacter baumanniiCarrying theblaOXA-143Gene in Brazilian Hospitals

(2010) Charline S. Antonio et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Characterization and PCR-Based Replicon Typing of Resistance Plasmids in Acinetobacter baumannii

(2010) A. Bertini et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Prevalence and diversity of carbapenemases among imipenem-nonsusceptible Acinetobacter isolates in Korea: emergence of a novel OXA-182

(2010) Chang-Ki Kim et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Novel genetic context of multiple blaOXA-58 genes in Acinetobacter genospecies 3

(2010) B. A. Evans et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Diversity, Epidemiology, and Genetics of Class D  -Lactamases

(2009) L. Poirel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

OXA-143, a Novel Carbapenem-Hydrolyzing Class D  -Lactamase in Acinetobacter baumannii

(2009) P. G. Higgins et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Inclusion of OXA-143 primers in a multiplex polymerase chain reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.

(2009) Paul G. Higgins et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Global spread of carbapenem-resistant Acinetobacter baumannii

(2009) P. G. Higgins et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

OXA-51-like β-lactamases and their association with particular epidemic lineages of Acinetobacter baumannii

(2008) B.A. Evans et al.   CLINICAL MICROBIOLOGY AND INFECTION

Acinetobacter baumannii: Emergence of a Successful Pathogen

(2008) A. Y. Peleg et al.   CLINICAL MICROBIOLOGY REVIEWS